[1]
“CLINICAL PROFILE AND TREATMENT RESULTS OF PATIENTS RECEIVING BPALM REGIMEN FOR DRUG-RESISTANT TUBERCULOSIS AT A TERTIARY CARE TEACHING HOSPITAL: A PROSPECTIVE OBSERVATIONAL STUDY”, A-JMRHS, vol. 4, no. 2, pp. 1084–1089, Jun. 2026, Accessed: Jul. 01, 2026. [Online]. Available: https://www.ajmrhs.com/journal/article/view/557